Nurse-led Telehealth for Rheumatoid Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a nurse-led telehealth system can improve care for people with rheumatoid arthritis. Participants will use an online tool to monitor their health from home and communicate with nurses, potentially making management more convenient and accessible, especially for those living far from clinics. The trial seeks adults who have had rheumatoid arthritis for at least six months and have recently experienced a flare-up or medication change. As an unphased trial, this study offers a unique opportunity to contribute to innovative care solutions that could enhance convenience and accessibility in managing rheumatoid arthritis.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment, as the study focuses on monitoring your health with a new tool.
What prior data suggests that this nurse-led telehealth approach is safe for rheumatoid arthritis patients?
Research has shown that nurse-led telehealth, which enables patients to manage their health from home, is generally safe and well-received. One study found that remote monitoring helps patients track their health, leading to better care without major safety issues. Patients reported no significant side effects when using these online tools to manage rheumatoid arthritis (RA), a condition that causes joint pain and swelling. Another study demonstrated that nurse-led telehealth support improves patients' experiences and outcomes without introducing new risks. This method has also been applied to other long-term diseases without major safety concerns. Overall, evidence suggests that this telehealth approach is safe for people with RA to manage their condition.12345
Why are researchers excited about this trial?
Researchers are excited about nurse-led telehealth for rheumatoid arthritis because it offers a personalized and proactive approach to disease management. Unlike traditional care, which often involves periodic in-person visits, this method employs remote self-monitoring, allowing patients to track their disease activity and symptoms monthly from home. Rheumatology nurses receive alerts when moderate or high disease activity is detected, enabling timely intervention and support. This approach not only empowers patients with tailored information and self-management tools but also enhances communication through asynchronous messaging, potentially leading to improved outcomes and patient satisfaction.
What evidence suggests that this nurse-led telehealth approach is effective for rheumatoid arthritis?
This trial will evaluate the effectiveness of nurse-led telehealth for managing rheumatoid arthritis (RA). Research has shown that nurse-led care effectively manages RA and can match the quality of care provided by rheumatologists. Participants will use nurse-led telehealth to monitor their health from home, which helps reduce symptoms like fatigue and depression. Digital tools in these programs assist patients in managing their condition more effectively. These methods also simplify access to quality care and enhance patient satisfaction.13678
Who Is on the Research Team?
Laetitia Michou, MD PhD
Principal Investigator
CHU de Quebec-Universite Laval
Are You a Good Fit for This Trial?
This trial is for adults (18+) with rheumatoid arthritis for at least six months, who recently had a flare-up or changed their medication. Participants must understand French or English and have internet access. People unable to consent or complete online questionnaires can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Intervention
Participants receive nurse-led remote self-monitoring of RA using an online platform for 16 months
Delayed Intervention
Participants receive usual care for 8 months followed by 8 months of nurse-led remote self-monitoring
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Nurse-led telehealth remote self-monitoring
Trial Overview
The study tests if nurse-led telehealth self-monitoring—where patients track their symptoms from home using an online tool reviewed by nurses—is easy to use and helpful compared to usual care in four Quebec clinics.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The intervention includes nurse-led remote self-monitoring of RA, with patients completing monthly self-assessments of disease activity (RADAI), symptoms and function (PROMIS-29). Rheumatology nurses will receive alerts if monitoring suggests moderate/high disease activity and will contact participants to determine care needed. Tailored information based on PROMIS-29 answers will be sent to facilitate self-management. Asynchronous messaging with rheumatology nurses and information on RA self-management will be available.
Usual care for 8 months, consisting in rheumatology visits scheduled every 3-6 months. Followed by the intervention for 8 months: The intervention includes nurse-led remote self-monitoring of RA, with patients completing monthly self-assessments of disease activity (RADAI), symptoms and function (PROMIS-29). Rheumatology nurses will receive alerts if monitoring suggests moderate/high disease activity and will contact participants to determine care needed. Tailored information based on PROMIS-29 answers will be sent to facilitate self-management. Asynchronous messaging with rheumatology nurses and information on RA self-management will be available.
Find a Clinic Near You
Who Is Running the Clinical Trial?
CHU de Quebec-Universite Laval
Lead Sponsor
The Arthritis Society, Canada
Collaborator
Citations
Acceptability of a Nurse-led Telehealth Remote Self ...
This new way of care, where nurses help patients monitor their rheumatoid arthritis from home, helps make better use of limited specialist time.
Effectiveness of nurse-led care in patients with rheumatoid ...
NLC proves highly effective in managing RA patients, surpassing usual care and equating to rheumatologist-led care in primary and some secondary outcomes.
An evaluation of the Virtual Monitoring Clinic, a novel nurse ...
In this study, we aimed to determine the effectiveness of the VMC in improving access to quality care in our rheumatology specialist center, by ...
Tele-health interventions to support self-management in ...
This study suggests that tele-health interventions that are well-designed, tailored and multi-faceted can help to achieve positive self-management outcomes in ...
Review The effectiveness of nurse-led care in people with ...
Nurse-led clinics ran alongside rheumatologists' clinic and they provided follow-up care for stable patients giving patient education, advice and support. This ...
6.
ctv.veeva.com
ctv.veeva.com/study/acceptability-of-a-nurse-led-telehealth-remote-self-monitoring-model-of-care-in-patients-with-rheumaAcceptability of a Nurse-led Telehealth Remote Self ...
The investigators will test a new way to help people with rheumatoid arthritis at four clinics in Quebec. This study will check if the new ...
Remote monitoring of patients with rheumatoid arthritis in a ...
This study evaluated the scale-up of a remote monitoring service, capturing monthly Rheumatoid Arthritis Impact of Disease scores and patient-generated text ...
8.
journals.lww.com
journals.lww.com/ijru/fulltext/2022/17003/review__remote_disease_monitoring_in_rheumatoid.6.aspxReview: Remote Disease Monitoring in Rheumatoid Arthritis
However, these treatments require close monitoring to ensure safe prescribing, and the best outcomes are associated with tight control of disease activity, ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.